- Report
- September 2024
- 156 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- March 2025
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- September 2024
- 174 Pages
Global
From €2050EUR$2,310USD£1,782GBP
- Report
- November 2024
- 525 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- November 2024
- 716 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- November 2024
- 799 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- September 2024
- 375 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- March 2025
- 262 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- April 2024
- 505 Pages
Global
€2329EUR$2,450USD£1,957GBP
- Report
- May 2024
- 224 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- March 2025
- 1048 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- December 2024
- 342 Pages
Global
From €5359EUR$5,835USD£4,350GBP
- Report
- February 2025
- 138 Pages
Global
From €2000EUR$2,254USD£1,739GBP
- Report
- September 2024
- 89 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- March 2025
- 1000 Pages
Global
From €3708EUR$3,900USD£3,115GBP
- Report
- October 2024
- 1300 Pages
Global
From €3708EUR$3,900USD£3,115GBP
- Report
- November 2024
- 240 Pages
Global
From €2282EUR$2,400USD£1,917GBP
- Report
- September 2024
- 180 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- June 2024
- 240 Pages
Global
From €2567EUR$2,700USD£2,156GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more